Mayne Pharma Launches Temozolomide Capsules in U.S. – Generic Alternative to Temodar®

Mayne Pharma Inc. (Mayne Pharma) is pleased to announce the U.S. launch of temozolomide capsules, 5mg, 20mg, 100mg, 140mg, 180mg and 250mg, which is a generic version of branded Temodar®. Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed cancerous brain tumors known as glioblastoma multiform concomitantly with radiotherapy and then as maintenance treatment. Temozolomide []

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us